Oliver v Simshauser

The case of *Oliver v Simshauser* concerned appeals from decisions of a single judge of the Supreme Court of New South Wales, which had affirmed the dismissal of four prosecutions against an auctioneer. The prosecutions, brought under various provisions of the *Stock Medicines Act 1989* and the *Stock Diseases (General) Regulation*, related to the sale of stock treated with hormonal growth promotants (HGPs) without the appropriate identification tags.

The primary legal issues before the Court of Appeal were whether the prosecution had adduced sufficient evidence to prove the auctioneer's guilt on each of the charges. Specifically, the court had to determine if the stock sold could be identified with the stock for which evidence of HGP treatment was presented, if the prescribed transaction identifiers had been approved by the Director-General, if the auctioneer had participated in the removal of such identifiers, and if the auctioneer had provided false or misleading information regarding chemical residues.

The Court of Appeal affirmed the decision of the primary judge, finding that the prosecution had failed to establish the necessary elements for each charge. The court held that there was a lack of identification between the stock sold and the stock to which the evidence of HGP treatment related. Furthermore, the prosecution failed to prove that the transaction identifiers used, or proposed to be used, had received the requisite approval from the Director-General. The court also found no evidence that the auctioneer had been involved in the removal of transaction identifiers, nor that the auctioneer had knowingly provided false or misleading information concerning chemical residues.

Consequently, the appeals were dismissed, and the auctioneer was awarded costs.